163 related articles for article (PubMed ID: 33356256)
1. Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis.
Li Z; Tu J; Han G; Liu N; Sheng C
J Med Chem; 2021 Jan; 64(2):1116-1126. PubMed ID: 33356256
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis.
Han G; Liu N; Li C; Tu J; Li Z; Sheng C
J Med Chem; 2020 May; 63(10):5341-5359. PubMed ID: 32347094
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicans.
Li C; Tu J; Han G; Liu N; Sheng C
Eur J Med Chem; 2022 Jan; 227():113961. PubMed ID: 34742014
[TBL] [Abstract][Full Text] [Related]
4. Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant
Xu J; Liu R; Sun F; An L; Shang Z; Kong L; Yang M
Front Cell Infect Microbiol; 2019; 9():211. PubMed ID: 31281800
[TBL] [Abstract][Full Text] [Related]
5. Discovery of BRD4-HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity against Fluconazole-Resistant
Li Z; Huang Y; Tu J; Yang W; Liu N; Wang W; Sheng C
J Med Chem; 2023 Apr; 66(8):5950-5964. PubMed ID: 37037787
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis.
Yang W; Tu J; Ji C; Li Z; Han G; Liu N; Li J; Sheng C
ACS Infect Dis; 2021 Mar; 7(3):650-660. PubMed ID: 33593060
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
8. Milbemycins: more than efflux inhibitors for fungal pathogens.
Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
[TBL] [Abstract][Full Text] [Related]
9. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
10. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
12. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
[TBL] [Abstract][Full Text] [Related]
13. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
14. Loss of Upc2p-Inducible
Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
mBio; 2018 May; 9(3):. PubMed ID: 29789366
[TBL] [Abstract][Full Text] [Related]
15. Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
Vale-Silva LA; Coste AT; Ischer F; Parker JE; Kelly SL; Pinto E; Sanglard D
Antimicrob Agents Chemother; 2012 Apr; 56(4):1960-8. PubMed ID: 22252807
[TBL] [Abstract][Full Text] [Related]
16. Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.
Yang DL; Hu YL; Yin ZX; Zeng GS; Li D; Zhang YQ; Xu ZH; Guan XM; Weng LX; Wang LH
Biomed Environ Sci; 2019 Mar; 32(3):199-209. PubMed ID: 30987694
[TBL] [Abstract][Full Text] [Related]
17. The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
Li Y; Yang J; Li X; Su S; Chen X; Sun S; Li Y
Int J Antimicrob Agents; 2020 Aug; 56(2):106030. PubMed ID: 32454072
[TBL] [Abstract][Full Text] [Related]
18. Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of
Li X; Zhao Y; Huang X; Yu C; Yang Y; Sun S
Front Cell Infect Microbiol; 2017; 7():124. PubMed ID: 28439502
[TBL] [Abstract][Full Text] [Related]
19. Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.
Shen H; An MM; Wang de J; Xu Z; Zhang JD; Gao PH; Cao YY; Cao YB; Jiang YY
Biol Pharm Bull; 2007 Jan; 30(1):68-73. PubMed ID: 17202662
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Pyrazolone Carbothioamide Derivatives as Inhibitors of the Pdr1-KIX Interaction for Combinational Treatment of Azole-Resistant Candidiasis.
Wang Q; Tu J; Yang W; Liang T; Liu N; Sheng C
J Med Chem; 2023 Sep; 66(17):11893-11904. PubMed ID: 37584282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
